Cargando…

CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment

Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTDs) have provided evidence‐based dementia diagnostic and treatment guidelines for Canadian clinicians and researchers. We present the results from the Neuroimaging and Fluid Biomarkers Group of the 5th C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brisson, Mélanie, Brodeur, Catherine, Létourneau‐Guillon, Laurent, Masellis, Mario, Stoessl, Jon, Tamm, Alex, Zukotynski, Katherine, Ismail, Zahinoor, Gauthier, Serge, Rosa‐Neto, Pedro, Soucy, Jean‐Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821956/ https://www.ncbi.nlm.nih.gov/pubmed/33532543 http://dx.doi.org/10.1002/trc2.12098

Ejemplares similares

CCCDTD5: research diagnostic criteria for Alzheimer's Disease
por: Gauthier, Serge, et al.
Publicado: (2020)

Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
por: Gauthier, Serge, et al.
Publicado: (2012)

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
por: Herrmann, Nathan, et al.
Publicado: (2022)

Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
por: Smith, Eric E., et al.
Publicado: (2020)

CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus
por: Montero‐Odasso, Manuel, et al.
Publicado: (2020)

CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales
por: Tang‐Wai, David F., et al.
Publicado: (2020)

CCCDTD5: Reducing the risk of later‐life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD‐5)
por: Rockwood, Kenneth, et al.
Publicado: (2020)

Neuroimaging in the early diagnosis of neurodegenerative disease
por: Stoessl, A Jon
Publicado: (2012)

Artificial intelligence for molecular neuroimaging
por: Boyle, Amanda J., et al.
Publicado: (2021)

CCCDTD5: Individual and community‐based psychosocial and other non‐pharmacological interventions to support persons living with dementia and their caregivers
por: Vedel, Isabelle, et al.
Publicado: (2020)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia
por: Ng, Kok Pin, et al.
Publicado: (2019)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
por: Ismail, Zahinoor, et al.
Publicado: (2020)

Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Burhan, Amer M, et al.
Publicado: (2013)

Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Soucy, Jean-Paul, et al.
Publicado: (2013)

Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data
por: Gill, Sascha, et al.
Publicado: (2020)

Ultra-wide angle neuroimaging: insights into immersive scene representation
por: Park, Jeongho, et al.
Publicado: (2023)

Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID‐19
por: Geddes, Maiya R., et al.
Publicado: (2020)

Incidentaloma Discoveries in the Course of Neuroimaging Research
por: Stip, Emmanuel, et al.
Publicado: (2019)

Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
por: van Eimeren, Thilo, et al.
Publicado: (2019)

Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy
por: Subotic, Arsenije, et al.
Publicado: (2021)

Early-onset dementias: diagnostic and etiological considerations
por: Masellis, Mario, et al.
Publicado: (2013)

The Role of Functional Neuroimaging in Pre-Surgical Epilepsy Evaluation
por: Pittau, Francesca, et al.
Publicado: (2014)

The Saskatchewan Movement Disorders Program: Commitment Pays Off
por: Lang, Anthony E., et al.
Publicado: (2015)

Affect and Arousal in Insomnia: Through a Lens of Neuroimaging Studies
por: Schiel, Julian E., et al.
Publicado: (2020)

Facial palsy after temporal lobectomy for epilepsy: illustrative cases
por: Lemoine, Émile, et al.
Publicado: (2021)

Fluorodeoxyglucose Uptake in Lipomatous Hypertrophy of the Interatrial Septum is Not Likely Related to Brown Adipose Tissue
por: Kim, Chun K., et al.
Publicado: (2015)

Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
por: Lussier, Firoza Z., et al.
Publicado: (2020)

Cholinergic Depletion in Alzheimer's Disease Shown by [(18)F]FEOBV Autoradiography
por: Parent, Maxime J., et al.
Publicado: (2013)

In vivo tau staging in Alzheimer’s disease
por: Therriault, Joseph, et al.
Publicado: (2022)

Applications of Alzheimer’s disease staging to clinical trials
por: Therriault, Joseph, et al.
Publicado: (2023)

Pandemic Dementia Scarce Resource Allocation
por: Smith, Eric E., et al.
Publicado: (2020)

The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system
por: Liu, Shu-Ying, et al.
Publicado: (2017)

COVID-19 and selective vulnerability to Parkinson's disease
por: Pavel, Alexandra, et al.
Publicado: (2020)

Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians
por: Rosa-Neto, Pedro, et al.
Publicado: (2013)

Neurosyphilis masquerading as oculomotor nerve palsy in a healthy middle-aged man: Case report and review of the literature
por: Antaki, Fares, et al.
Publicado: (2021)

(18)F-MK-6240 tau-PET in genetic frontotemporal dementia
por: Levy, Jake P, et al.
Publicado: (2021)

Targeted Radionuclide Therapy: Practical Applications and Future Prospects
por: Zukotynski, Katherine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nhn8jlqdvnki68igpl3h96nidj